Suspended

Assessment of Insulin Resistance and Secretory Capacity for Type 2 Diabetes Prevention in High-Risk Population

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study aims to assess your insulin resistance and secretory capacity, with the goal of preventing Type 2 Diabetes, if you are identified as a high-risk individual.

What is being tested

Data Collection

Who is being recruted

Diabetes Mellitus+4

+ Diabetes Mellitus, Type 2

+ Endocrine System Diseases

From 10 to 20 Years
See all eligibility criteria
How is the trial designed

Prevention Study

Interventional
See protocol details

Summary

Principal SponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Last updated: January 14, 2026
Sourced from a government-validated database.Claim as a partner

This is a pilot study to examine the prevalence of metabolic risk factors (impaired insulin release and impaired insulin sensitivity) for type 2 diabetes mellitus in children and adults from a population that is at high risk for this disease. We hypothesize that at least one of these pre-diabetic traits will be evident in a large proportion of relatives of known type 2 diabetic children as compared to a control group of subjects without a family history of type 2 diabetes. By isolating these traits, it will be possible to determine the relative contributions of genes and environment to each trait and to identify those at risk for subsequent development of type 2 diabetes by virtue of having one trait. Ultimately, those individuals at risk, especially those with impaired insulin release, would hopefully benefit from intervention to prevent the weight gain that will 'unmask' their underlying pancreatic dysfunction and thus prevent or retard the development of type 2 diabetes.

Official TitlePhenotypic Assessment of Insulin Resistance and Insulin Secretory Capacity 
NCT00073294
Principal SponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Last updated: January 14, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Prevention Study

Prevention studies aim to stop a disease from developing. They often involve people at risk and test things like vaccines, lifestyle changes, or preventive medications.


Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 10 to 20 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Diabetes MellitusDiabetes Mellitus, Type 2Endocrine System DiseasesHyperinsulinismInsulin ResistanceMetabolic DiseasesGlucose Metabolism Disorders

Criteria

Ascertainment criteria for probands: * age 10-20 years and * obesity (BMI \>85% for sex and age) * diabetic criteria as described above or family history (first or second degree relative) with type 2 diabetes

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 2 locations

Suspended

Columbia Presbyterian Medical Center/ Irving Center

New York, United StatesSee the location
Suspended

Russ Berrie Pavilion

New York, United States
Suspended2 Study Centers